The Low Carb Diabetic

Promoting a low carb high fat lifestyle for the safe control of diabetes. Eat whole fresh food, more drugs are not the answer.


Welcome to the Low Carb Diabetic forum,have you signed up yet? if not then sign up and join us in the low carb community today!

    Another Study Ties Pioglitazone (Actos) to Bladder Cancer Risk

    Share
    avatar
    graham64
    Member

    Status :
    Online
    Offline

    Male Posts : 2925
    Join date : 2014-08-10
    Location : Lancs

    Another Study Ties Pioglitazone (Actos) to Bladder Cancer Risk

    Post by graham64 on Thu Aug 10 2017, 22:31

    The saga of whether pioglitazone (Actos) increases risk of bladder cancer took another turn with a new analysis of Medicare data showing an elevated risk compared with two other classes of type 2 diabetes drugs.

    Patients taking pioglitazone had an incidence of bladder cancer of 308 per 100,000 person-years versus 204 per 100,000 person-years with dipeptidyl peptidase-4 (DPP-4) inhibitors for an adjusted hazard ratio of 1.57 (95% CI 1.23-2.00) in an "as-treated" analysis, found Elizabeth M. Garry, MPH, of University of North Carolina at Chapel Hill, and colleagues.
    The rate with pioglitazone was also higher than for sulfonylureas (231 per 100,000 person-years; adjusted HR 1.32, 95% CI 1.02-1.70), they reported online in Diabetes, Obesity and Metabolism.

    http://www.medpagetoday.com/Endocrinology/Diabetes/67194


    _________________
    I'm a skinny T2 diagnosed 4/4/2008, a high calorie LCHF diet and one metformin a day A1c 6.2 and no complications.

    Proving the LowCarb sceptics wrong for over nine years,

    Not all cherubs are Angels  Wink nor all diabetics Bonkers  Rolling Eyes
    avatar
    Jan1
    Member

    Status :
    Online
    Offline

    Female Posts : 4094
    Join date : 2014-08-13

    Re: Another Study Ties Pioglitazone (Actos) to Bladder Cancer Risk

    Post by Jan1 on Sat Aug 12 2017, 19:47

    @graham64 wrote:The saga of whether pioglitazone (Actos) increases risk of bladder cancer took another turn with a new analysis of Medicare data showing an elevated risk compared with two other classes of type 2 diabetes drugs.

    Patients taking pioglitazone had an incidence of bladder cancer of 308 per 100,000 person-years versus 204 per 100,000 person-years with dipeptidyl peptidase-4 (DPP-4) inhibitors for an adjusted hazard ratio of 1.57 (95% CI 1.23-2.00) in an "as-treated" analysis, found Elizabeth M. Garry, MPH, of University of North Carolina at Chapel Hill, and colleagues.
    The rate with pioglitazone was also higher than for sulfonylureas (231 per 100,000 person-years; adjusted HR 1.32, 95% CI 1.02-1.70), they reported online in Diabetes, Obesity and Metabolism.

    http://www.medpagetoday.com/Endocrinology/Diabetes/67194

    Certainly something to be aware of ...

    All the best Jan

      Current date/time is Mon Aug 21 2017, 10:56